Wayne Godfrey
2021
In 2021, Wayne Godfrey earned a total compensation of $4.3M as Chief Medical Officer at Janux Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $102,818 |
|---|---|
| Option Awards | $3,918,086 |
| Salary | $257,045 |
| Total | $4,277,949 |
Godfrey received $3.9M in option awards, accounting for 92% of the total pay in 2021.
Godfrey also received $102.8K in non-equity incentive plan and $257K in salary.
Rankings
In 2021, Wayne Godfrey's compensation ranked 3,108th out of 12,406 executives tracked by ExecPay. In other words, Godfrey earned more than 74.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,108 out of 12,406 | 75th |
Division Manufacturing | 1,247 out of 5,492 | 77th |
Major group Chemicals And Allied Products | 504 out of 2,368 | 79th |
Industry group Drugs | 446 out of 2,089 | 79th |
Industry Pharmaceutical Preparations | 306 out of 1,536 | 80th |
Source: SEC filing on April 29, 2022.
Godfrey's colleagues
We found two more compensation records of executives who worked with Wayne Godfrey at Janux Therapeutics in 2021.